Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies

Brás, Inês C., Outeiro, Tiago F.·2021·Cells
DOI 10.3390/cells10020375

Cited by (136)

Items 101–136 of 136

  1. Cellular prion protein and calcium ions trigger the neurotoxicity of α-synuclein aggregates
    Alessandra Bigi, Andrea Carlotta Conti, Liliana Napolitano, Giuliana Fusco, Alfonso De Simone, Fabrizio Chiti, Roberta Cascella, Cristina Cecchi · 2025 · Cell & Bioscience
  2. Impact of Gender and Race on Gastrointestinal Diseases in Patients With Parkinson's Disease: A Nationwide Analysis
    Mohamed H. Eldesouki, Ahmed Yasser Shaban, Mohamed Mahmoud Marey, Eslam Mohammed Rabea, Abdulrhman Helal, Mohamed Seisa, Omar Abdelhalim, Hazem Maarouf Abosheaishaa, Mohamed Mahmoud Khalaf · 2026 · JGH Open
  3. Beyond Amyloids: Neuroprotective Potential of Betanin and its Derivatives Against Alpha-Synuclein Aggregates and ROS Overload in Parkinson’s Disease
    Ayda Ghahari, Alireza Alikhanian, Fatemeh Akhond Solaei, Arghavan Fattahi, Hamdam Hourfar, Anett Schallmey, Mehdi Mohammadi, Dina Morshedi · 2026 · Journal of Molecular Neuroscience
  4. HMC3 revealed: how much do these “Microglia” really tell us?
    Lucia Buccarello, Anna Privitera, Konstantinos Partsinevelos, Karolina Serwa, Giuseppe Carota, Lucia Di Pietro, Vincenzo Cardaci, Renata Mangione, Jay Sibbitts, Giuseppe Lazzarino et al. · 2026 · Frontiers in Immunology
  5. THE EFFECTS OF DIFFERENT SONICATION METHODS ON ALPHA-SYNUCLEIN PRE-FORMED FIBRILS
    Hilal Akyel, Elham Bahador Zırh, Selim Zırh, Banu Cahide Tel · 2024 · Eskişehir Teknik Üniversitesi Bilim ve Teknoloji Dergisi - C Yaşam Bilimleri Ve Biyoteknoloji
  6. Synuclein Proteoforms: Role in Health and Disease
    Fatima Tu Zahra, Hooreen Kayani, Samra Noreen, Aneeqa Noor, Saima Zafar · 2025 · Molecular Neurobiology
  7. Systematic comparison of the molecular mechanisms underlying the spreading of pathology in different neurodegenerative diseases
    Inês Caldeira Brás · 2021
  8. Alpha-synuclein-associated alterations at the synapse in models of Parkinson’s disease
    Patrícia I. Santos · 2023
  9. Fear Memory in Experimental Models of Parkinson’s Disease
    Elena Timofeeva, Nina I. Dubrovina, Maria A. Tikhonova, Tamara G. Amstislavskaya · 2024 · Advances in Gerontology
  10. Characterization of the Phosphomimetic Mutant Y39E of a-Synuclein
    Nicola Martina Böffinger · 2024
  11. Merging iPSCs and “omics”: Advances in the field and potential applications to untangle neurodegenerative diseases
    Linn Streubel-Gallasch, Philip Seibler · 2024 · Elsevier eBooks
  12. Advances in neurotransmitter detection and modulation: Implications for neurological disorders
    Rohit Ramesh Doke, Ajay A Bhagwat, Priyanka Tambe, Payal Vare, Sanghmitra More, Saurabh Nagare, Aniket Shinde · 2024 · IP International Journal of Comprehensive and Advanced Pharmacology
  13. Sensitivity and Specificity of the Diagnostic Method for Detecting α-Synuclein as a Histological Marker for Parkinson's Disease in Salivary Gland Tissues: a Systematic Review and Meta-analysis
    Kristina Konstantinovna Khacheva, Sergey Nikolaevich Illarioshkin, Alexey V. Karabanov · 2024 · Annals of Clinical and Experimental Neurology
  14. Evaluating Alpha-Synuclein Neuropathy and Consequences for Birdsong in Zebra Finch Basal Ganglia Area X
    Reed T. Bjork, Famesh Patel, Madeleine S. Daly, Julie E. Miller · 2025 · SSRN Electronic Journal
  15. An In Vivo Model of α-Synuclein Spread from Gut to Brain
    Lisa M. Barnhill, Sataree Khuansuwan, Wael Noor El-Nachef, Sung Min Ha, Marisol Arellano, Kazi Md Mahmudul Hasan, Aaron Kim, Jeff M. Bronstein · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  16. Advanced gene therapy in Parkinson’s disease through innovations in drug delivery systems
    Phuong-Anh Tran Nguyen, Thuy-vi Nguyen, Soyeun Park · 2025 · Journal of Pharmaceutical Investigation
  17. Advancing Amyloid Aggregation Research: A Focus on Innovative Therapies, Molecular Modeling and Nano-Delivery Systems in Alzheimer’s Disease
    Umaira Hasan, Himangini Jain, Ruhi Ali · 2025 · Current Drug Targets
  18. Structure-Based Docking and Interaction Profiling of Kyp-2047 with Α-Synuclein Fibrils: An In-Silico Study
    Kaustubh Raundal, Gauresh Ghuge, Digambar Hinge · 2025 · SSRN Electronic Journal
  19. Deletion or Targeted Blockade of FcγRIIb (CD32b) Impairs α-Syn Propagation In-Vivo
    James M. Hennegan, Michael J. Hurley, Kerry L. Cox, Leon R. Douglas, Patrick J. Duriez, Robert J. Oldham, Mark Steven Cragg, Björn Frendéus, Ali Roghanian, Jessica L. Teeling · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  20. From Kitchen Spice to Neuroprotector: The Role of 6-Shogaol in Parkinson’s Disease Management
    Jiahui Jin, Xiran Li, Yunxi Wang, Zishu Yan, Airong Lv, Yanjun Zhang, Pengwei Zhuang, Hong Guo · 2025 · Journal of Agricultural and Food Chemistry
  21. Additional file 1 of Integration of National Health Insurance claims data and animal models reveals fexofenadine as a promising repurposed drug for Parkinson’s disease
    Kim, Jae-Bong, Kim, Yujeong, Kim, Soo-Jeong, Ha, Tae‑Young, Kim, Dong-Kyu, Kim, Dong Won, M. L. So, Kim, Seung Ho, Hyun Goo Woo, Yoon, Dukyong et al. · 2024 · Figshare
  22. In situ NMR and integrative proteomics reveal the interaction signature of serum α-synuclein
    Jinfeng Huang, Rashik Ahmed, Madoka Akimoto, José Carlos Bozelli, Richard M. Epand, Giuseppe Melacini · 2026 · Proceedings of the National Academy of Sciences
  23. LRRK2-I1371V Disrupts Astrocyte Membrane Homeostasis and Paradoxically Enhances α-Synuclein Toxicity Despite Impaired Clearance
    Indrani Datta, Roon Banerjee, VikramVenkayappa Holla, Nitish L. Kamble, Ravi Yadav, Pramod Kumar Pal · 2026 · Research Square
  24. Neuroprotective effect of RMF in a mouse model of sporadic Parkinson's disease
    Umer Anayyat, Xueying Mei, Fen Zhang, Ruiqi Yi, Xiaolu Yang, Zhuohang Yang, Kan Li, Guangsen Zheng, Yunpeng Wei, Xiaomei Wang · 2026 · Experimental Neurology
  25. Evaluation of the role of parkin in the direct and indirect transcriptional regulation of alpha-synucléine in Parkinson's disease
    Lígia Ramos dos Santos · 2023 · theses.fr (ABES)
  26. LAG-3 as a dual-modulator of neuroimmune surveillance and α-synuclein propagation in Parkinson’s disease and Lewy body dementia
    A. M. Mukherjee · 2026 · Discover Neuroscience
  27. Un « mécanisme prion » impliqué dans la progression de la maladie de Parkinson : vers des approches thérapeutiques innovantes ?
    Thierry Baron · 2026 · médecine/sciences
  28. Phytochemical engineered quantum dots as potential therapy to counter alpha synuclein aggregation in Parkinson's disease
    Priya Shashwat, Vishnu Kirthi Arivarasan, Manickam Selvaraj, Arun Karnwal, Joydeep Dutta · 2026 · Neurochemistry International
  29. Propagation of α-synuclein pathology: models, mechanisms and future goals
    Aryeh Zolin, Sarah A. Weber, Yan Xin Xie, Jacqueline Burré · 2026 · Molecular Neurodegeneration Advances
  30. Nanocarriers focusing on synuclein misfolding as a therapeutic target
    Komal Parmar, Jayvadan Patel, Aakash Jethva · 2026 · Elsevier eBooks
  31. Glial control of extracellular α-synuclein propagation in LRRK2 Parkinson’s disease
    Indrani Datta, Dibyam Debasish Sahu · 2026 · Advances in immunology
  32. Autophagy and molecular chaperones in neurodegenerative disease
    Riddhi Upadhyay, Nagaraj Rangappa, Murugan Sevanan, Subashchandrabose Chinnathambi · 2026 · Advances in protein chemistry and structural biology
  33. KLF4 in Parkinson’s Disease: Decoding the Molecular Puzzle of Neuroinflammation, Oxidative Stress, and Emerging Therapies
    Anjali Kumari, Khadga Raj Aran · 2026 · Current Medical Science
  34. Rebalancing α-Synuclein Clearance: Novel Therapeutic Frontiers in Parkinson’s Disease
    Maryam Jabeen, Huma Hameed, Syed Muhammad Ahmad, Tehreem Mushtaq, Mahtab Ahmad Khan, Anam Hameed · 2026 · NeuroMolecular Medicine
  35. Deletion or immunotherapeutic blockade of FcγRIIb (CD32b) impairs α-Syn propagation in vivo
    James M. Hennegan, Michael J. Hurley, Matthew Colley, Kerry L. Cox, Leon R. Douglas, Patrick J. Duriez, Robert J. Oldham, Mark Steven Cragg, Björn Frendéus, Ali Roghanian et al. · 2026 · Acta Neuropathologica
  36. Probing the Energy Landscape of α‐Synuclein Amyloid Fibril Formation by Systematic K‐to‐Q Mutagenesis
    Antonín Kunka, Azad Farzadfard, Jacob Aunstrup Larsen, Rasmus K. Norrild, Federica Saraceno, Celia Fricke, Hossein Mohammad‐Beigi, Ahmed Sadek, Jonas Folke, Susana Aznar et al. · 2026 · Advanced Science